| Oocyte donation: a risk factor for pregnancy-induced hypertension: a meta-analysis and case series. | |
| | |
MedLine Citation:
|
PMID: 21285999 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: In 2008 and 2009, the authors saw in their institution three women who had undergone oocyte donation and went on to develop severe de novo hypertension before the 26(th) week of gestation, with values above 180/110 mm Hg. Pregnancy was prematurely terminated in these cases because of the acute threat to the mother's life, and none of the three neonates survived. Five further cases with better outcomes were found to have occurred from 2006 to 2010. On the basis of this experience, the authors performed a meta-analysis to determine whether oocyte donation elevates the risk of pregnancy-induced hypertension (PIH). The cases are discussed in detail. METHODS: Systematic review of the literature on PIH after oocyte donation, with meta-analysis and calculation of an odds ratio. We also provide a retrospective chart review of our own case series. RESULTS: 28 publications were evaluated. The overall rate of PIH in a total of 2308 deliveries after oocyte donation was 22.6%. With the aid of data from 11 studies, the course of pregnancy in a total of 644 oocyte recipients was compared to that in a control group of 2320 women who were not oocyte recipients. The calculated odds ratio for PIH after oocyte donation, compared to conventional reproductive therapy, was 2.57 (95% CI, 1.91-3.47), while the calculated odds ratio for PIH after oocyte donation, compared to other women in the control group, was 6.60 (95% CI, 4.55-9.57). CONCLUSION: The data reveal that oocyte donation confers a considerable risk that the recipient will develop PIH. The very early and severe cases of preeclampsia that we report here are rather atypical; similar cases may have occurred elsewhere without finding their way into the relevant literature. The authors recommend close surveillance of pregnancies following allogenic oocyte transplantation by physicians with special expertise in prenatal medicine. |
| | |
Authors:
|
Ulrich Pecks; Nicolai Maass; Joseph Neulen |
Related Documents
:
|
21279129 - Teratogenic risk of drugs used in early pregnancy. 21364609 - Maternal health behaviours during pregnancy in an irish obstetric population and their ... 21410829 - Fetal scalp stimulation test: an adjunct to intermittent auscultation in non-reassuring... 3987279 - Chloroquine and premature evacuation of uterine conceptus in rats. 21516919 - Factors related to dimensions of grief intensity among african-american women after pre... 21490789 - Labour and neonatal outcome in small for gestational age babies delivered beyond 36+0 w... 11779599 - Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating h... 12971159 - Liver and kidney function tests in normal and pre-eclamptic gestation--a comparison wit... 17598009 - The effect of dalteparin on coagulation activation during pregnancy in women with throm... |
Publication Detail:
|
Type: Case Reports; Journal Article; Meta-Analysis Date: 2011-01-21 |
Journal Detail:
|
Title: Deutsches Ärzteblatt international Volume: 108 ISSN: 1866-0452 ISO Abbreviation: Dtsch Arztebl Int Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2011-02-02 Completed Date: 2011-06-03 Revised Date: 2011-07-25 |
Medline Journal Info:
|
Nlm Unique ID: 101475967 Medline TA: Dtsch Arztebl Int Country: Germany |
Other Details:
|
Languages: eng Pagination: 23-31 Citation Subset: IM |
Affiliation:
|
Frauenklinik für Gynäkologie und Geburtsmedizin, Universitätsklinikum der RWTH Aachen, Pauwelsst. 30, 52057 Aachen, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Female Humans Hypertension, Pregnancy-Induced / epidemiology* Incidence Middle Aged Oocyte Donation / statistics & numerical data* Pregnancy Risk Assessment Risk Factors |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Neonatal screening for metabolic and endocrine disorders.
Next Document: The diagnosis and treatment of soft tissue sarcomas of the limbs.